Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Concord Drugs

BSE: 538965|ISIN: INE858L01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 18, 11:52
30.60
-0.4 (-1.29%)
VOLUME 782
Concord Drugs is not listed on NSE
Announcements on Concord Drugs

12th-Jan-2018 16:00Source: BSE

Concord Drugs- Shareholding for the Period Ended December 31, 2017

Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly

12th-Jan-2018 15:36Source: BSE

Concord Drugs- Statement Of Investor Complaints For The Quarter Ended 31.12.2017

statement of investor complaints for the quarter ended 31.12.2017

14th-Dec-2017 19:49Source: BSE

Concord Drugs- Outcome of Board Meeting

Outcome of board meeting

14th-Dec-2017 19:47Source: BSE

Concord Drugs- Financial Results For The Quarter Ended 30.09.2017

Financial results for the quarter ended 30.09.2017

13th-Dec-2017 16:31Source: BSE

Concord Drugs- Board Meeting Postponed

Sub: Postponement of Board Meeting
Ref: Scrip Code 538965

With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of M/s. Concord ...

1st-Dec-2017 18:04Source: BSE

Concord Drugs- Closure of Trading Window

Closure of trading window

1st-Dec-2017 18:03Source: BSE

Concord Drugs- Board Meeting On 13.12.2017

Board meeting on 13.12.2017

23rd-Nov-2017 13:49Source: BSE

Concord Drugs- Shareholding for the Period Ended November 15, 2017

Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 15, 2017. For more details, kindly

17th-Nov-2017 14:17Source: BSE

Concord Drugs- Updates

Sub: Resignation of Company Secretary cum Compliance officer with effect from16.11.2017


With reference to the subject cited, this is to inform the Exchange that Ms.AakankshaShukla, Comp...

15th-Nov-2017 18:47Source: BSE

Concord Drugs- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy

1 2 3 4 5 Next >>
Quick Links for Concord Drugs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.